Healthy Lifestyle Program for Heart Disease Risk Reduction
(MBC2 Trial)
Trial Summary
What is the purpose of this trial?
This trial tests the MBC2 program, which uses an app, fitness tracker, health coaching, and rewards to improve diet and exercise habits. It targets adults in rural Appalachia, Kentucky who have poor health profiles. The program helps participants track their habits, get personalized advice, and earn rewards for meeting health goals.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications, but it does exclude those taking weight loss medication.
What data supports the effectiveness of the treatment Adapted MBC2 Program, Stress Management Control for heart disease risk reduction?
Research shows that lifestyle programs focusing on diet, exercise, stress management, and social support can significantly improve heart health. These programs have been effective in reducing risk factors like blood pressure and cholesterol, and improving quality of life in people with heart disease.12345
Is the Healthy Lifestyle Program for Heart Disease Risk Reduction safe for humans?
How is the Adapted MBC2 Program treatment different from other treatments for heart disease risk reduction?
The Adapted MBC2 Program is unique because it focuses on a comprehensive lifestyle modification approach, which includes multiple components like physical exercise, healthy eating habits, and psychological support to improve adherence and reduce heart disease risk factors, unlike standard treatments that may focus solely on medication or single lifestyle changes.411121314
Research Team
Eligibility Criteria
This trial is for adults living in Appalachian Kentucky who want to improve their health habits. Participants should be willing to use a smartphone app and wear an accelerometer, spend over 90 minutes daily on recreational screen time, eat less than 4.5 cups of fruits/vegetables daily, engage in less than 150 minutes of physical activity weekly, and consume more than 8% of their calories from saturated fat.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the adapted MBC2 or stress management program, utilizing a smartphone app, accelerometers, telephone coaching, and behavioral incentives to improve diet and physical activity or manage stress.
Follow-up
Participants are monitored for changes in diet, activity, and health-related outcomes after the intervention period.
Treatment Details
Interventions
- Adapted MBC2 Program (Behavioural Intervention)
- Stress Management Control (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nancy Schoenberg
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Dr. Gary H. Gibbons
National Heart, Lung, and Blood Institute (NHLBI)
Chief Executive Officer since 2012
MD from Harvard Medical School
Dr. James P. Kiley
National Heart, Lung, and Blood Institute (NHLBI)
Chief Medical Officer since 2011
MD from University of California, San Francisco